Table 1.
Resolvins and Protectins in Animal Disease Models*
| Disease model | Species | Action(s) | References |
|---|---|---|---|
| Resolvin E1 | |||
| Periodontitis | Rabbit | Reduces neutrophil infiltration; prevents connective tissue and bone loss; promotes healing of diseased tissues; regenerates of lost soft tissue and bone | [32] |
| Peritonitis | Mouse | Stops neutrophil recruitment; regulates chemokine/cytokine production Promotes lymphatic removal of phagocytes | [11, 18, 25] |
| Dorsal air pouch | Mouse | Stops neutrophil recruitment | [1] |
| Retinopathy | Mouse | Protects against neovascularization | [28] |
| Colitis | Mouse | Decreases neutrophil recruitment and proinflammatory gene expression; improves survival; reduces weight loss | [31] |
| Mouse | Reduces weight loss, colon shortening and thickening, and PMN infiltration | [110] | |
| Bacterial infection (P. gingivalis) | Rat | Reduces edema formation and PMN infiltration. Reduces kinin B1 receptor and TNF-α expression |
[111] |
| Corneal injury | Mouse | Reduces PMN and MF infiltration. Regulates IL-1β, TNF-α, and VEGF Protects against eye neovascularization |
[98] |
| Insulin resistance and Fatty Liver Disease | Mouse | Protects against hepatic steatosis. Reduces macrophage infiltration in adipose tissue. Increases adiponectin, GLUT-4, IRS-1, and PPAR-γ |
[112] |
| Asthma | Mouse | Reduces airway leukocyte infiltration and expedites airway inflammation resolution. Reduces IL-23, 27, 6, and LTB4 release. Increases IFN-g and LXA4 Improves lung function |
[113] |
| Mouse | Reduces airway leukocyte infiltration and expedites airway inflammation. Reduces IgG E and IL-13 |
[114] | |
| Resolvin D1 | |||
| Peritonitis | Mouse | Stops neutrophil recruitment | [19, 21] |
| Dorsal skin air pouch | Mouse | Stops neutrophil recruitment | [2, 19] |
| Kidney ischemia-reperfusion | Mouse | Protects from ischemia-reperfusion-induced kidney damage and loss of function; regulates macrophages and protects from fibrosis | [107] |
| Retinopathy | Mouse | Protects against neovascularization | [28] |
| Corneal injury | Mouse | Reduces PMN and MF infiltration. Regulates IL-1β, TNF-α, and VEGF Protects against eye neovascularization |
[98] |
| Hind limb ischemia/second organ injury | Mouse | Reduces neutrophil infiltration into the lungs | [27] |
| Peritonitis | Mouse | Reduces neutrophil infiltration | [115] |
|
| |||
| Protectin D1 | |||
| Peritonitis | Mouse | Stops neutrophil recruitment; regulates chemokine/cytokine production Promotes lymphatic removal of phagocytes Regulates T-cell migration |
[11, 18, 25, 116] |
| Asthma | Mouse | Protects from lung damage, airway inflammation and airway hyperresponsiveness | [117] |
| Human | Protectin D1 is generated in humans and appears to be diminished in asthmatics | [117] | |
| Kidney ischemia-reperfusion | Mouse | Protects from ischemia-reperfusion-induced kidney damage and loss of function; regulates macrophages and is anti-fibrotic | [107] |
| Retinopathy | Mouse | Protects against neovascularization | [28] |
| Ischemic stroke | Rat | Stop leukocyte infiltration, inhibits NF-κB and cyclooxygenase-2 induction | [23] |
| Alzheimer’s disease | Human | Diminished protectin D1 production in human Alzheimer’s disease |
[118] |
| Insulin resistance and Fatty Liver Disease | Mouse | Increase adiponectin | [112] |
| Ischemic renal injury | Mouse | Reduces kidney neutrophil infiltration. Increases hemeoxygenase-1 expression |
[119] |
The actions of each of the main resolvins and protectins, i.e., RvE1, RvD1 and PD1, were confirmed with compounds prepared by total organic synthesis (see text and cited references for further details).